PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Media

Media

Welcome to BioMarin's Online Press Room.

We've brought together a variety of information in one location to better assist you in your efforts to research and develop news articles. Should you require additional information, please call or e-mail us any time.

Contact Information:
415-455-7451
corporatecommunications2@BMRN.com

Recent News

  • BioMarin Announces FDA Accepts Drisapersen NDA for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping...  MORE >
  • BioMarin Announces EMA Validates MAA for Drisapersen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping...  MORE >
  • BMN 111 (vosoritide) Improves Growth Velocity in Children With Achondroplasia in Phase 2 Study...  MORE >